| Date |
Title |
Download |
| 03/10/08 |
Clinuvel Newsletter - October 2008 |
Download |
| 30/09/08 |
Financial Report Year Ended 30 June 2008 |
Download |
| 23/09/08 |
Clinuvel commences Phase II trial in Photodynamic Therapy |
Download |
| 10/09/08 |
Amended Becoming a substantial holder notice (ASX online) |
Download |
| 05/09/08 |
Becoming a substantial holder (ASX online) |
Download |
| 04/09/08 |
Ceasing to be a substantial holder (ASX online) |
Download |
| 04/09/08 |
Ceasing to be a substantial holder (ASX online) |
Download |
| 02/09/08 |
International and Australian investors buyout substantial shareholder |
Download |
| 29/08/08 |
Appendix 4E |
Download |
| 01/08/08 |
Open Briefing - FDA Orphan Drug Designation Approval |
Download |
| 31/07/08 |
Appendix 4C |
Download |
| 29/07/08 |
FDA grants Clinuvel orphan-drug designation |
Download |
| 28/07/08 |
Open Briefing - Strategy & Clinical Program Update |
Download |
| 14/07/08 |
Appendix 3X - Initial Director's Interest Notice |
Download |
| 08/07/08 |
New Non-Executive Director |
Download |
| 02/07/08 |
Appendix 3B |
Download |
| 01/07/08 |
Clinuvel Newsletter - July 2008 |
Download |
| 17/06/08 |
World Health Organisation Assigns CUV1647 Generic Name |
Download |
| 11/06/08 |
Corporate Presentation - FINSIA Lifesciences Showcase |
Download |
| 11/06/08 |
Clinuvel receives approval to begin Phase II Trials in Solar Urticaria |
Download |
| 30/04/08 |
Appendix 4C |
Download |
| 28/04/08 |
Swissmedic grants Clinuvel Orphan Drug Status for CUV1647 |
Download |
| 23/04/08 |
Clinuvel's latest pharmacokinetic studies further validate human safety of CUV1647 |
Download |
| 19/04/08 |
Update Investor Presentation April 2008 |
Download |
| 31/03/08 |
Clinuvel Newsletter - March 2008 |
Download |
| 25/03/08 |
Teleconference transcript of Investor Update held 19 March 2008 |
Download |
| 14/03/08 |
Clinuvel Investor Update via teleconference |
Download |
| 13/03/08 |
Corporate Briefing on Orphan Medicinal Product Designations |
Download |
| 12/03/08 |
EMEA grants Clinuvel two orphan drug designations |
Download |
| 29/02/08 |
Appendix 4D Half Yearly Report |
Download |
| 05/02/08 |
Appendix 3B |
Download |
| 31/01/08 |
Appendix 4C |
Download |
| 10/01/08 |
Response to price query |
Download |
| 20/12/07 |
Open Briefing Clinuvel CEO on Commercialisation Goals |
Download |
| 06/12/07 |
Clinuvel Pharmaceuticals Ltd appoints new Chair |
Download |
| 27/11/07 |
Teleconference transcript of Investor Update held 22 November 2007 |
Download |
| 20/11/07 |
Clinuvel's second regular investor update via teleconference |
Download |
| 16/11/07 |
Clinuvel opens Europe office |
Download |
| 16/11/07 |
AGM 2007 Results of Meeting |
Download |
| 16/11/07 |
Clinuvel AGM Presentation |
Download |
| 31/10/07 |
Clinuvel’s drug begins global Phase II skin cancer trials |
Download |
| 31/10/07 |
Appendix 4C |
Download |
| 15/10/07 |
Annual Report 2007 |
Download |
| 15/10/07 |
AGM Notice of Meeting |
Download |
| 02/10/07 |
Open Briefing 2 October 2007 |
Download |
| 27/09/07 |
Financial Report Year Ended 30 June 2007 |
Download |
| 26/09/07 |
Clinuvel Shareholder Update 19 September 2007 Conference Call |
Download |
| 25/09/07 |
Conference Call and Weblink |
Download |
| 24/09/07 |
Shareholder Update Repeat Conference Call |
Download |
| 20/09/07 |
Shareholder Update |
Download |
| 19/09/07 |
Clinuvel initiates regular investor update via teleconference – Updated contact numbers |
Download |
| 07/09/07 |
Appendix 3Y |
Download |
| 30/08/07 |
Amendment to Appendix 4E |
Download |
| 29/08/07 |
Appendix 4E and Preliminary Financial Report |
Download |
| 21/08/07 |
Clinuvel Appoints Head of Corporate Development |
Download |
| 03/08/07 |
Appendix 3B |
Download |
| 27/07/07 |
Appendix 4C |
Download |
| 19/07/07 |
Selection of final dosage for development of CUV1647 |
Download |
| 10/07/07 |
Dr Aston appointed to Goverment Committee |
Download |
| 04/07/07 |
End of Financial Year Report to Shareholders |
Download |
| 03/07/07 |
Clinuvel relocates Melbourne office |
Download |
| 03/07/07 |
Clinuvel Newsletter - Issue No 2 - June 2007 |
Download |
| 28/06/07 |
Open Briefing®. Clinuvel. Update on Start of Phase III |
Download |
| 07/06/07 |
Appendix 3Z - Final Director’s Interest Notice |
Download |
| 06/06/07 |
Appendix 3B - Application for Quotation of Additional Securities |
Download |
| 06/06/07 |
Phase III trial begins in Erythropoietic Protoporphyria |
Download |
| 01/06/07 |
Clinuvel Share Purchase Plan completed |
Download |
| 01/06/07 |
Clinuvel board member resigns |
Download |
| 21/05/07 |
Phase III trial of CUV1647 begins in Polymorphic Light Eruption |
Download |
| 11/05/07 |
Clinuvel Share Purchase Plan |
Download |
| 10/05/07 |
Correction to Appendix 3B – Application for Quotation of Additional Securities |
Download |
| 07/05/07 |
Appendix 3B - Application for Quotation of Additional Securities |
Download |
| 27/04/07 |
Appendix 4C March 2007 Quarterly Report |
Download |
| 26/04/07 |
Clinuvel Completes A$26M Private Placement |
Download |
| 23/04/07 |
Request for Trading Halt |
Download |
| 11/04/07 |
Clinuvel receives approval to begin Phase III trials in EPP |
Download |
| 03/04/07 |
Strategic Update to Investors |
Download |
| 26/03/07 |
Clinuvel Newsletter - Issue No 1 - March 2007 |
Download |
| 20/03/07 |
Open Briefing. Clinuvel. CUV1647 Treatment of PDT |
Download |
| 20/03/07 |
New Oncology application identified for CUV1647 |
Download |
| 27/02/07 |
Appendix 4D Half Year Report |
Download |
| 22/02/07 |
Clinuvel reports first positive Phase II clinical trial results of CUV1647 in new indication -EPP |
Download |
| 16/02/07 |
Appendix 3Y Change of Director's Interest Notice |
Download |
| 09/02/07 |
Appendix 3B New issue announcement, application for quotation of additional securities |
Download |
| 07/02/07 |
Appendix 3X Ms Brenda Shanahan |
Download |
| 06/02/07 |
New Non-Executive Director |
Download |
| 31/01/07 |
Open Briefing Clinuvel Phase III PLE Trials |
Download |
| 31/01/07 |
Clinuvel receives medical ethics approval to begin a Phase III trial in the UK |
Download |
| 30/01/07 |
Appendix 4C December 2006 Quarterly Report |
Download |
| 25/01/07 |
EGM Results |
Download |
| 24/01/07 |
Clinuvel receives approval to begin Phase III trials |
Download |
| 22/01/07 |
Appendix 3B |
Download |
| Date |
Title |
Download |
